Moss; Bernard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moss; Bernard.The latest application filed is for "intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus".

Company Profile

3.44.30

Moss; Bernard - Bethesda MD
Moss; Bernard - Tyldesley GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Virus-based expression vectors and uses thereof Grant 10,894,966 - Moss , et al. January 19, 2	2021-01-19
Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus App 20200071724 - Moss; Bernard ; et al.	2020-03-05
Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus Grant 10,421,978 - Moss , et al. Sept	2019-09-24
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites Grant 9,879,231 - Moss , et al. January 30, 2	2018-01-30
Virus-based Expression Vectors And Uses Thereof App 20170298387 - MOSS; Bernard ; et al.	2017-10-19
Monoclonal antibodies against orthopoxviruses Grant 9,708,392 - Chen , et al. July 18, 2	2017-07-18
Monoclonal Antibodies Against Orthopoxviruses App 20170114120 - CHEN; Zhaochun ; et al.	2017-04-27
Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes Grant 9,453,239 - Moss , et al. September 27, 2	2016-09-27
Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus App 20160040188 - Moss; Bernard ; et al.	2016-02-11
Recombinant Modified Vaccinia Ankara (MVA) Vaccinia Virus Containing Restructured Insertion Sites App 20160040135 - Moss; Bernard ; et al.	2016-02-11
Compositions and methods for generating an immune response Grant 9,254,319 - Robinson , et al. February 9, 2	2016-02-09
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites Grant 9,133,480 - Moss , et al. September 15, 2	2015-09-15
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes Grant 9,133,478 - Moss , et al. September 15, 2	2015-09-15
Monoclonal Antibodies Against Orthopoxviruses App 20150252098 - CHEN; Zhaochun ; et al.	2015-09-10
Mva Expressing Modified Hiv Envelope, Gag And Pol Genes App 20150238593 - MOSS; BERNARD ; et al.	2015-08-27
Compositions And Methods For Generating An Immune Response App 20150231227 - Robinson; Harriet L. ; et al.	2015-08-20
Monoclonal antibodies against Orthopoxviruses Grant 8,999,336 - Chen , et al. April 7, 2	2015-04-07
Compositions And Methods For Generating An Immune Response App 20150004132 - Robinson; Harriet ; et al.	2015-01-01
MVA expressing modified HIV envelope, gag, and pol genes Grant 8,916,172 - Moss , et al. December 23, 2	2014-12-23
Monoclonal Antibodies Against Orthopoxviruses App 20130251704 - CHEN; Zhaochun ; et al.	2013-09-26
Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell Grant 8,506,947 - McCart , et al. August 13, 2	2013-08-13
Monoclonal antibodies against orthopoxviruses Grant 8,404,818 - Chen , et al. March 26, 2	2013-03-26
Recombinant Modified Vaccinia Ankara (mva) Vaccinia Virus Containing Restructured Insertion Sites App 20120263750 - Moss; Bernard ; et al.	2012-10-18
Compositions, methods and kits relating to poxvirus subunit vaccines Grant 8,124,105 - Cohen , et al. February 28, 2	2012-02-28
Monoclonal Antibodies Against Orthopoxviruses App 20110243840 - Chen; Zhaochun ; et al.	2011-10-06
MVA expressing modified HIV envelope, GAG, and POL genes App 20110159036 - Moss; Bernard ; et al.	2011-06-30
MVA Expressing Modified HIV Envelope, GAG, and POL Genes App 20110104199 - Moss; Bernard ; et al.	2011-05-05
Monoclonal antibodies against orthopoxviruses Grant 7,914,788 - Chen , et al. March 29, 2	2011-03-29
MVA expressing modified HIV envelope, gag, and pol genes Grant 7,867,982 - Moss , et al. January 11, 2	2011-01-11
Intergenic Sites Between Conserved Genes In The Genome Of Modified Vaccinia Ankara (mva) Vaccinia Virus App 20100143402 - Moss; Bernard ; et al.	2010-06-10
Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines App 20100021484 - Cohen; Gary H. ; et al.	2010-01-28
Compositions, methods and kits relating to poxvirus subunit vaccines Grant 7,560,116 - Cohen , et al. July 14, 2	2009-07-14
Monoclonal Antibodies Against Orthopoxviruses App 20090155250 - Chen; Zhaochun ; et al.	2009-06-18
Mva Expressing Modified Hiv Envelope, Gag, And Pol Genes App 20090074726 - MOSS; Bernard ; et al.	2009-03-19
VAC-BAC shuttle vector system Grant 7,494,813 - Moss , et al. February 24, 2	2009-02-24
Recombinant Mva Viruses Expressing Clade A/G, Clade B, and Clade C Modified Hiv Env Gag and Pol Genes App 20080193483 - Moss; Bernard ; et al.	2008-08-14
MVA expressing modified HIV envelope, gag, and pol genes Grant 7,303,754 - Moss , et al. December 4, 2	2007-12-04
Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector App 20070154458 - McCart; J. Andrea ; et al.	2007-07-05
Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector Grant 7,208,313 - McCart , et al. April 24, 2	2007-04-24
Compositions and methods for generating an immune response App 20070048861 - Robinson; Harriet L. ; et al.	2007-03-01
MVA expressing modified HIV envelope, Gag, and Pol genes App 20060134133 - Moss; Bernard ; et al.	2006-06-22
Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences Grant 7,045,136 - Moss , et al. May 16, 2	2006-05-16
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA Grant 7,045,313 - Moss , et al. May 16, 2	2006-05-16
Compositions, methods and kits relating to poxvirus subunit vaccines App 20060062800 - Cohen; Gary H. ; et al.	2006-03-23
Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences Grant 7,015,024 - Moss , et al. March 21, 2	2006-03-21
Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences Grant 6,998,252 - Moss , et al. February 14, 2	2006-02-14
VAC-BAC shuttle vector system App 20050124070 - Moss, Bernard ; et al.	2005-06-09
Transmission blocking immunogen from malaria Grant 6,780,417 - Kaslow , et al. August 24, 2	2004-08-24
MVA expressing modified HIV envelope, gag, and pol genes App 20040146528 - Moss, Bernard ; et al.	2004-07-29
Transmission Blocking Vaccine Against Malaria App 20030049278 - KASLOW, DAVID C. ; et al.	2003-03-13
Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector App 20030031681 - McCart, J. Andrea ; et al.	2003-02-13
Oligomeric HIV-1 envelope glycoproteins Grant 6,171,596 - Earl , et al. January 9, 2	2001-01-09
In vitro ligation of foreign DNA into large eukaryotic viruses Grant 5,866,383 - Moss , et al. February 2, 1	1999-02-02
Recombinant vaccinia virus expressing human retrovirus gene Grant 5,849,304 - Moss , et al. December 15, 1	1998-12-15
Enterically administered recombinant poxvirus vaccines Grant 5,676,950 - Small, Jr. , et al. October 14, 1	1997-10-14
Cytotoxic agent against specific virus infection Grant 5,587,455 - Berger , et al. December 24, 1	1996-12-24
Prokaryotic expression in eukaryotic cells Grant 5,550,035 - Moss , et al. August 27, 1	1996-08-27
Vector for recombinant poxvirus expressing rabies virus glycoprotein Grant 5,348,741 - Esposito , et al. * September 20, 1	1994-09-20
CD-4/cytotoxic gene fusions Grant 5,206,353 - Berger , et al. April 27, 1	1993-04-27
Synthetic, anti-complement protein Grant 5,157,110 - Kotwal , et al. October 20, 1	1992-10-20
Gene encoding serine protease inhibitor Grant 5,151,509 - Kotwal , et al. September 29, 1	1992-09-29
Rapid, versatile and simple system for expressing genes in eukaryotic cells Grant 5,135,855 - Moss , et al. * August 4, 1	1992-08-04
Stable mammalian cell line expressing a bacteriophage RNA polymerase Grant 5,126,251 - Moss , et al. June 30, 1	1992-06-30
Post-foaming gel shower product Grant 4,772,427 - Dawson , et al. September 20, 1	1988-09-20
Vaccine for vesicular stomatitis virus Grant 4,738,846 - Rose , et al. April 19, 1	1988-04-19

Company Registrations

NCAGE Code	36LX3	MOSS BERNARD
CAGE Code	36LX3	MOSS, BERNARD

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.